Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Molecular Cell|November 4, 2006
Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complexDouglas I Lin, Olena Barbash, K G Suresh Kumar, et al.
Molecular Cancer Research : MCR|October 6, 2011
Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinomaJianbo Wang, Kaihua Zhang, Dorota Grabowska, et al.
Plos One|January 7, 2011
The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in miceDaniel A Rauch, Michelle A Hurchla, John C Harding, et al.
Cancer Research Communications|December 18, 2025
Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell LinesAlexander Zheleznyak, Dhanusha Duraiyan, Prasanth Thunuguntla, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Cell Reports|May 16, 2019
Acetate Promotes T Cell Effector Function during Glucose RestrictionJing Qiu, Matteo Villa, David E Sanin, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis SensitivityChe-Pei Kung, Nick D Terzich, Ma Xenia G Ilagen, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Nature Communications|January 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trialTim Kong, Alex Mabry, Maureen Highkin, et al.
Pageof 7